Your browser doesn't support javascript.
loading
Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.
Willis, Brian A; Sundell, Karen; Lachno, D Richard; Ferguson-Sells, Lisa R; Case, Michael G; Holdridge, Karen; DeMattos, Ronald B; Raskin, Joel; Siemers, Eric R; Dean, Robert A.
  • Willis BA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Sundell K; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Lachno DR; Eli Lilly and Company, Windlesham, UK.
  • Ferguson-Sells LR; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Case MG; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Holdridge K; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • DeMattos RB; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Raskin J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Siemers ER; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Dean RA; Siemers Integration, LLC, Zionsville, IN, USA.
Alzheimers Dement (N Y) ; 4: 652-660, 2018.
Article en En | MEDLINE | ID: mdl-30511011

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2018 Tipo del documento: Article